Recently, genetic association studies in humans demonstrated that common polymorphisms in the Fgf21 signaling pathways were associated with metabolic risks and syndromes, such as high cholesterol and body mass risks [12], obesity and diabetes [13] and even dietary macronutrient intake [14]. Here, FGF21 is linked to obesity disorder.